Related references
Note: Only part of the references are listed.Microenvironmental interleukin-6 suppresses toll-like receptor signaling in human leukemia cells through miR-17/19A
Yanmei Li et al.
BLOOD (2015)
Statin Use and Survival After Colorectal Cancer: The Importance of Comprehensive Confounder Adjustment
Michael Hoffmeister et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Statin Use and Survival After Colorectal Cancer: The Importance of Comprehensive Confounder Adjustment
Michael Hoffmeister et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Cholesteryl Ester Accumulation Induced by PTEN Loss and PI3K/AKT Activation Underlies Human Prostate Cancer Aggressiveness
Shuhua Yue et al.
CELL METABOLISM (2014)
Chronic lymphocytic leukemia in young (≤ 55 years) patients: a comprehensive analysis of prognostic factors and outcomes
Sameer A. Parikh et al.
HAEMATOLOGICA (2014)
A role for oleoylethanolamide in chronic lymphocytic leukemia
M. Masoodi et al.
LEUKEMIA (2014)
Impact of Age and Gender on the Prevalence and Prognostic Importance of the Metabolic Syndrome and Its Components in Europeans. The MORGAM Prospective Cohort Project
Julie K. K. Vishram et al.
PLOS ONE (2014)
The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: Insight into disease biology and new targeted therapies
Jan A. Burger et al.
SEMINARS IN CANCER BIOLOGY (2014)
The Pathogenesis of Chronic Lymphocytic Leukemia
Suping Zhang et al.
Annual Review of Pathology-Mechanisms of Disease (2013)
Prevalence and Trends of Metabolic Syndrome in the Adult U.S. Population, 1999-2010
Hiram Beltran-Sanchez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
PPAR-alpha is a therapeutic target for chronic lymphocytic leukemia
D. E. Spaner et al.
LEUKEMIA (2013)
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia
Davide Rossi et al.
BLOOD (2012)
Risk categories and refractory CLL in the era of chemoimmunotherapy
Thorsten Zenz et al.
BLOOD (2012)
Metabolic Syndrome and Risk of Cancer A systematic review and meta-analysis
Katherine Esposito et al.
DIABETES CARE (2012)
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
Victor Quesada et al.
NATURE GENETICS (2012)
Statin Use and Reduced Cancer-Related Mortality
Sune F. Nielsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The metabolic syndrome
Robert H. Eckel et al.
LANCET (2010)
Statin use and need for therapy in chronic lymphocytic leukemia
Daphne R. Friedman et al.
LEUKEMIA & LYMPHOMA (2010)
Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemia
Tait D. Shanafelt et al.
LEUKEMIA & LYMPHOMA (2010)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
For Patients with Colorectal Cancer, the Long-Term Use of Statins Is Associated with Better Clinical Outcomes
Ali A. Siddiqui et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Pathogenesis and Pathophysiology of the Cardiometabolic Syndrome
Erik P. Kirk et al.
JOURNAL OF CLINICAL HYPERTENSION (2009)
High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: A population-based Canadian cohort
M. D. Seftel et al.
LEUKEMIA RESEARCH (2009)
Diabetes and the risk of non-Hodgkin's lymphoma and multiple myeloma in the European Prospective Investigation into Cancer and Nutrition
Aneire E. Khan et al.
HAEMATOLOGICA (2008)
Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology
Graca A. M. Dores et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia
William G. Wierda et al.
BLOOD (2007)
Incidence rates of the major leukemia subtypes among US Hispanics, Blacks, and non-Hispanic Whites
Matthew J. Matasar et al.
LEUKEMIA & LYMPHOMA (2006)
Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphomna
Jia Ruan et al.
CLINICAL CANCER RESEARCH (2006)
Genomic aberrations and survival in chronic lymphocytic leukemia.
H Döhner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
